US FDA granted BTD designation to Blue Arbor’s RESTORE Neuromuscular Interface System and accepted for Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot (enables FDA and medical device sponsors collaboration to accelerate development and commercialization of innovative devices in breakthrough program)
RESTORE, a Robotic Prosthetic control system that creates effortless coordination between the Patient’s Residual muscles and Nervous system to prosthetic upper limbs to reinstate the natural function of the arm
The device enables independent movement of wrist, arms, and elbow joints surpassing surface skin electrodes; constant motor signal captured over past 5 yrs in early feasibility human trials
Ref: Blue Arbor | Image: Blue Arbor
Related News:- Simpson’s Acolyte Image Guided Crossing and Re-Entry Catheter System Gains the US FDA’s Breakthrough Device Designation
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
